Effects of HIS1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues-Reference-Cited by-同舟云学术

Effects of HIS1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues

Published:1984-09 Issue:5 Volume:5 Page:877-881
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Robberecht P.,Waelbroeck M.,Camus J.C.,De Neef P.,Coy D.,Christophe J.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference24 articles.

1. Synthesis, biological and immunochemical properties of analogues of secretin and vasoactive intestinal peptide (VIP): the vasectrins;Beyerman;Life Sci,1981

2. The information content of the sequences of secretin and VIP;Bodanszky,1977

3. Synthesis and pharmacological properties of the N-terminal decapeptide of the vasoactive intestinal peptide (VIP);Bodanszky;J Med Chem,1977

4. Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide;Bodanszky,1973

5. Glucagon amino groups. Evaluation of modifications leading to antagonism and agonism;Bregman;J Biol Chem,1980

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of PACAP in the Regulation of Body Temperature;Current Topics in Neurotoxicity;2016

2. Transcriptional modulation by VIP: a rational target against inflammatory disease;Clinical Epigenetics;2011-05-18

3. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery;Pharmacological Reviews;2009-09

4. Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians;Microscopy Research and Technique;2001-07-10

5. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages;European Journal of Pharmacology;1997-03